• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Travis Ford Admits Guilt in $9M Fraud Case

user avatar

by Giorgi Kostiuk

10 months ago


Travis Ford, the co-founder of Wolf Capital, has admitted guilt in defrauding investors of $9 million. The case is being adjudicated in a federal court in Oklahoma.

Case Details

Court documents reveal that from January to September 2023, Ford solicited investments from 2,800 investors both domestically and internationally. He has pled guilty to wire fraud charges.

DoJ Statement

According to the U.S. Department of Justice, Ford promised investment returns of 1-2% per day, equating to approximately 547% annually. He has admitted he did not believe these returns were consistently achievable.

Ford presented himself as capable of providing high returns, admitting this was impossible.

Legal Consequences

Prosecutors indicate Ford has pled guilty to one count of wire fraud, which carries a maximum sentence of five years in prison.

The case highlights the importance of regulatory oversight in investment activities and the need to protect investor rights by adhering to financial laws.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Crypto Derivatives Industry Faces Structural Critique

chest

A fresh bout of soulsearching has gripped the crypto derivatives industry as leading market participants argue that the market's structure is fundamentally flawed.

user avatarDavid Robinson

Bitcoin Hyper Revolutionizes Smart Contracts on Bitcoin

chest

Bitcoin Hyper aims to address Bitcoin's limitations by introducing a high-speed execution layer for smart contracts.

user avatarAndrew Smith

BioAge Labs Focuses on Metabolic Aging with AI

chest

BioAge Labs is utilizing machine learning to explore metabolic aging and develop treatments for metabolic disorders.

user avatarAyman Ben Youssef

Neumora Therapeutics Targets Brain Diseases with AI

chest

Neumora Therapeutics is developing AI-driven solutions for treating brain diseases, including schizophrenia and Alzheimer's.

user avatarSon Min-ho

Relay Therapeutics Innovates Drug Discovery with AI

chest

Relay Therapeutics is using its AI-powered platform to enhance drug discovery processes in oncology.

user avatarJacob Williams

AI Advances in Biotech: Nobel Prize Winners and Promising Companies

chest

In 2024, the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John Jumper for their groundbreaking work in using machine learning to design entirely new proteins, highlighting the growing role of AI in biotech.

user avatarTando Nkube

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.